These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20080265)

  • 1. Angiotensin II receptor type 1 is upregulated in atrial tissue of patients with rheumatic valvular disease with atrial fibrillation.
    Cong H; Li X; Ma L; Jiang H; Mao Y; Xu M
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):298-304. PubMed ID: 20080265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of mineralocorticoid receptor and 11-beta-hydroxysteroid dehydrogenase type 2 in human atria during chronic atrial fibrillation: study of 25 cases].
    Pei DA; Li L; Xu ZY; Zou LJ; Zhang BR; Huang SD; Hao JH; Wang ZN; Lu FL
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):816-9. PubMed ID: 17565863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The relation between angiotensin II receptors 1 and 2, and CYP11B2 and atrial structural remodeling in patients with atrial fibrillation].
    Wu YQ; Wang XD; Fang H; Wang YL; Zhang YC; Su LJ
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2281-4. PubMed ID: 18001553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation.
    Zhao F; Zhang S; Shao Y; Wu Y; Qin J; Chen Y; Chen L; Gu H; Wang X; Huang C; Zhang W
    Int J Cardiol; 2013 Oct; 168(3):2177-85. PubMed ID: 23465222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation in pure rheumatic mitral valvular disease is expression of an atrial histological change.
    Alessandri N; Tufano F; Petrassi M; Alessandri C; Di Cristofano C; Della Rocca C; Gallo P
    Eur Rev Med Pharmacol Sci; 2009; 13(6):431-42. PubMed ID: 20085124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
    Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
    Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression.
    Goette A; Bukowska A; Lendeckel U; Erxleben M; Hammwöhner M; Strugala D; Pfeiffenberger J; Röhl FW; Huth C; Ebert MP; Klein HU; Röcken C
    Circulation; 2008 Feb; 117(6):732-42. PubMed ID: 18227384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atrial 11beta-hydroxysteroid dehydrogenase type 2 expression in rheumatic heart disease patients with or without atrial fibrillation].
    Pei DA; Li L; Xu ZY; Huang JY; Xu ZM; Wang M
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 May; 36(5):385-9. PubMed ID: 19100026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of angiotensin II receptor subtypes in atrial fibrillation underlying rheumatic heart disease].
    Jiang H; Ma LJ; Cong HL; Jiang N; Mao YM; Xu ML; Cui RZ
    Zhonghua Nei Ke Za Zhi; 2009 Jul; 48(7):535-8. PubMed ID: 19957790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in gelatinases expression and activity in human atria during atrial fibrillation].
    Ke D; Xu CX; Zhang JC; Chen L; Lin YZ; Lin LF; Hu XZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb; 33(2):137-42. PubMed ID: 15924808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Left atrial electric isolation in the treatment of atrial fibrillation secondary to rheumatic valvular disease].
    Graffigna A; Pagani F; Minzioni G; Salerno J; Viganò M
    G Ital Cardiol; 1992 Aug; 22(8):785-93. PubMed ID: 1478389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation.
    Gaborit N; Steenman M; Lamirault G; Le Meur N; Le Bouter S; Lande G; Léger J; Charpentier F; Christ T; Dobrev D; Escande D; Nattel S; Demolombe S
    Circulation; 2005 Jul; 112(4):471-81. PubMed ID: 16027256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of chronic atrial fibrillation combined with rheumatic mitral valve disease: Effects of the cryo-maze procedure and predictors for late recurrence.
    Baek MJ; Na CY; Oh SS; Lee CH; Kim JH; Seo HJ; Park SW; Kim WS
    Eur J Cardiothorac Surg; 2006 Nov; 30(5):728-36. PubMed ID: 17008109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on expression of mineralocorticoid receptor in human atria during atrial fibrillation].
    Pei DA; Li L; Xu ZY; Zou LJ; Zhang BR; Huang SD; Hao JH; Wang ZN; Lu FL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Feb; 35(2):114-8. PubMed ID: 17445401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between atrial fibroblast proliferation/fibrosis and atrial fibrillation in patients with rheumatic heart disease].
    Lin YZ; Cai JM; Chen L; Yang ZP; Zhang JC; Wu W; Ke D; Xu CX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Sep; 37(9):813-7. PubMed ID: 20128380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of three different ablative procedures to treat atrial fibrillation in patients with valvular heart disease: a randomised trial.
    Srivastava V; Kumar S; Javali S; Rajesh TR; Pai V; Khandekar J; Agrawal N; Patwardhan AM
    Heart Lung Circ; 2008 Jun; 17(3):232-40. PubMed ID: 18242137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical on molecular basis of atrial fibrosis in patients with atrial fibrillation investigation].
    Ke D; Xu CX; Lin YZ; Zhang JC; Chen L; Lin LF; Hu XZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):459-63. PubMed ID: 15932710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial remodeling after mitral valve surgery in patients with permanent atrial fibrillation.
    Hornero F; Rodriguez I; Buendía J; Bueno M; Dalmau MJ; Canovas S; Gil O; Garcia R; Montero JA
    J Card Surg; 2004; 19(5):376-82. PubMed ID: 15383046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
    Wang W; Zhang HT; Yang XL
    J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):265-9. PubMed ID: 22929563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of matrix metalloproteinase-9 and tissue inhibitor-1 of metalloproteinase expression on atrial structural remodeling during chronic atrial fibrillation].
    Zhu H; Zhang W; Guo CH; Zhang G; Zhang WD; Zhong M; Yang GR; Ge ZM; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):45-8. PubMed ID: 15808077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.